Blue Horseshoe Stocks: NFLX Recap & More

Netflix, Inc. NFLX – Options Recap

On Tuesday morning after Netflix came out with its quarterly report and soundly exceeded expectations, we entered an options idea for the NFLX chain into the log in our premarket report.

We followed up with a recap of the gains made possible on Wednesday, which ranged from 65-100% but after a continuation of its bullish trend through yesterday, we observed some excellent new highs.24.50-

So we want to finish off the week by updating the figures on the total possible gains in our highlighted NFLX contracts, from Tuesday’s lows to yesterday’s highs.

$247.50 Calls – Range: 4.87-24.50 – Max Gain: 403%
$250 Calls – Range: 3.66-22.30 – Max Gain: 509%
$252.50 Calls – Range: 2.68-19.80 – Max Gain: 639%
$255 Calls - Range: 1.90-17.30 – Max Gain: 811%

_________

Fresh Idea:
Intel Corp. INTC Weekly $47.50-48.50*

*Please do not attempt to trade weekly options on a Friday unless you are an expert level trader with disposable funds. It’s one of the riskiest activities out there!



MannKind Corp. MNKD

We’ve been following MNKD for quite a long while, that’s why at the end of last month when we saw the stock fall to its lowest PPS since before the huge run back in the fall, we immediately signaled it as a bottom-watch play.

That was the morning of December 22nd, just prior to the holiday break. The stock saw its low of 2.30 the following session, on December 26th, and has since recovered much of the ground it had lost. Yesterday, possibly as the result of a short squeeze, the stock soared to a high of 4.05. That works out to a respectable 76% upswing in just one month’s time.

It remains to be seen if the stock can retest the impressive highs we saw from it back in October.


Extended Watchlist:
BOLD, ENRJ, HGT, RAS, LMFA, NBEV, MYSZ, GALT,

Incoming search terms:

  • RLUG

Blue Horseshoe Stocks: DAL, GALT Updates & More


Delta Air Lines, Inc. DAL  – Options Recap

We followed a range of Delta options beginning on Thursday morning, when we signaled the DAL Weekly $57-58 Calls in the wake of the company’s across-the-board Q4 earnings beat. We were glad to report on Friday that in a single session those three sets of contracts yielded gains ranging from roughly 780% to 1980%

Despite making such big moves already, Friday’s session brought more success for our tracked calls, so we wanted to open up this short trading week with a final recap on the maximum gains allowed by those excellent weekly contracts. The total ranges we observed over just two sessions were amazing.

$57 Calls – Range: .24-3.44 – Max Gain: 1313%
$57.50 Calls – Range: .14-2.96 – Max Gain: 2014%
$58 Calls – Range: .06-2.40 – Max Gain: 3900%


Galectin Therapeutics, Inc. GALT

We also want to swing back around for GALT, a stock we routinely tracked throughout 2017. It finished off that yea with a bang, and has continued its excellent run into 2018.

From lows it saw at the beginning of December at 1.28, to the new highs it made at the end of last week at 6.15 , GALT had executed a 380% increase in roughly five weeks!


Extended Watchlist:
NCTY, HEB, BB, OSIS, OTIV, HAWK

Blue Horseshoe Stocks: Fresh Options Ideas & More

First we’d like to apologize for our email list members for the absence of yesterday’s premarket report. Our service provider was shut down for the most of the day rendering us unable to send our daily report via email. This is an exceedingly rare event, but in these cases, you can always bookmark and visit BlueHorseshoeStocks.com just before market open, as all of our newsletters are archived there for easy reference.

Alcobra Ltd. ADHD

We did include ADHD in yesterday’s report, but since many of readers happened to miss it, we’ll back up to the next most recent mention, when we alerted the stock on September 29th.

The stock did see sub-1.00 prices that day, but took a couple more sessions to see its low of .96. Since then ADHD has been on a steady run-up, culminating in a new high of 2.17, which represented a very nice 127% move in a three week period.


PayPal Holdings, Inc. PYPL

We want to highlight a range of options for PYPL after the company posted its quarterly earnings after market close yesterday. The stock has been on a nearly continual rise all year long, and in premarket trading today, PYPL shares have rocketed into blue skies, setting a new annual high with each uptick.

As we often do in these post-earnings beat gap-up situations, we’ll identify a set of options contracts in the PYPL chain to observe as things kick off this morning, in this case, the PYPL Weekly $71-72.50 Calls* for potential quick strike trades today.

*Important: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.



AcelRx Pharmaceuticals, Inc. ACRX

ACRX recently fell off a cliff after the FDA rejected the company’s NDA for its Dsuvia drug, however ACRX believes it can meet the accompanying guidelines to eventually submit a successful application. We did alert that event in last Friday’s report, and meanwhile, the stock is gapping up this morning after having seen and bounced off of new annual lows yesterday. 

Recovering even a fraction of the ground it lost last week, could spell significant upswings for ACRX in coming sessions.


Extended Watchlist:
 AUPH, GALT, HMNY, INFI, ONVO, NEOT, BAC,

Blue Horseshoe Stocks: NIHD Review & More

NII Holdings, Inc. NIHD

We initially tagged NIHD in our premarket report from last Thursday, and on that day we would observe a low of .5472 in the stock. It’s been stepping its way up, but this morning in premarket trading things have really kicked into high gear, with NIHD cracking through the dollar barrier.

As of this morning’s premarket high of 1.14, we’ve now witnessed an increase of 108% in NIHD over a span of just three trading sessions. In order for us to remain highly interested in this play, we’ll want to see it maintain support at or above its current 50DMA of .83 on any pullbacks that may occur.


Celsion Corp. CLSN

We called out CLSN in yesterday morning’s premarket report, and saw a modest yet respectable move out of that play as well. From a low of 3.85 the stock ran as high as 4.96, marking an intraday move of 29%

The stock was number four on the NASDAQ’s top gainer list for the day, and while it did end up tapering back to close near its daily lows, this morning it is gapping up again in the premarket. This surge of activity is primarily due to yesterday’s announcement of positive results in its ovarian cancer treatment trials.

We’ll definitely be keeping CLSN on our radars and watching for the continued establishment of higher lows off of our recently observed bottom.


Bitcoin Services, Inc. BTSC

BTSC was a part of the bitcoin watchlist we issued on May 25th in the midst of a bitcoin frenzy where the crypto-currency was soaring to new all-time highs.

The residual effect for plays like BTSC has been impressive, with with stocks PPS making a jump from our observed low of  .0366 up to a new high of .164 yesterday, which represents a 348% rip which occurred over a period of just seven sessions.


Egalet Corp. EGLT

Not only is EGLT coming off of a bottom on the chart, but in the space of the past 36 hours, the company has made two major announcements.

Yesterday, it was made known that EGLT had “received a U.S. patent for its proprietary Guardian™ Technology tablet architecture used to create precise delivery of combination products with immediate-, delayed- and/or extended-release properties.” (>>View PR)

Today, the announcement was that “one of the largest payers in the United States will provide coverage of ARYMO® ER (morphine sulfate) extended-release tablets” (>>View PR)


Extended Watchlist:
KMI, GAHC, EBIO, GALT, IAG, BLDP, SBGL

Blue Horseshoe Stocks: Bottom-Bouncers & More


North Atlantic Drilling Ltd. NADL

We’ve got an array of potential bottom-bounce plays to go over this morning, the first of which is NADL. This stock has been getting beaten down incrementally since reaching a high of 4.80 in December. It’s been one selloff after another since then, culminating in a low of .65 during yesterday’s session.

We’re seeing a moderate gap-up this morning, and want to put NADL on our watchlist moving forward on the chance that a multi-day rebound is on the way.

__________

Catalyst BioSciences, Inc. CBIO

Next up on our bottom-bounce watchlist is CBIO, which is also gapping up off of a bottom in the premarket this morning with the help of a key press release, of which we’ll include a snippet below.

The stock recently made a massive run to the $18, so the potential for another major move is certainly present.

SOUTH SAN FRANCISCO, Calif., April 11, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc., (Nasdaq:CBIO) a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that it has achieved a key milestone under its collaboration with ISU Abxis to advance the Factor IX program towards its first human clinical trial. Completion of the CB 2679d/ISU304 toxicology studies supported the recent Investigational New Drug (IND) approval by the Korean Ministry of Food and Drug Safety (MFDS) and triggered a milestone payment to Catalyst. (>>View Full PR)
__________

Sunshine Heart, Inc. SSH

We tagged SSH as a bottom play a week ago today on the 4th, and subsequently tracked it over a pretty nice run last week as it traded up from 1.67 and hit 2.25 (+35%). It pulled back to the low 1.70′s yesterday and appears to be gearing up for another possible move.

Just two months ago the stock was trading at more than $5/share, so we wanted to add a little reminder this morning that SSH could be line for an extended recovery that we’ll want to look out for in the day and weeks ahead.


Galectin Therapeutics, Inc. GALT

We were just mentioning yesterday morning the excellent move from GALT we had witnessed between first bringing it up in January and the present. The run, originating at a low of .935 had already reached just beyond the 200% level, and after a very nice intraday performance, our observed range was extended even further.

Trading up from a morning low to 2.75, the stock traded up 34% to reach 3.68. That pushed the overall percentage gain we’ve witnessed in GALT for 2017 to a highly respectable 294%


Extended Watchlist:
AMLH, SALE, GLBS, AKER, STAF